Perri Goldberg

Perri Goldberg currently serves as the Director of HCP Marketing at Arcutis Biotherapeutics, Inc., specializing as the Psoriasis Indication Lead with a focus on portfolio media and digital strategies since April 2024. Prior experience includes a progression of roles in HCP marketing and medical specialties at Regeneron, where Perri significantly contributed to the DUPIXENT brand from July 2018 to April 2024. Perri holds an MBA in Entrepreneurship from Washington University in St. Louis and a B.S. in Sports Management from New York University, where involvement as a student athlete included competing in NCAA tournaments and serving on the Student Athletic Academic Committee. Additional internships in various sectors such as compliance, business analysis, and financial management further solidify Perri's diverse skill set and commitment to professional growth.